CYCLOPHARM LIMITED — Director's Dealing 2017

Apr 2, 2017

Appendix 3X
Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available.  Information and
documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity	Cyclopharm Limited
ABN	74 116 931 250

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent
for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Thomas ArthurMcDONALD
Date of appointment	3 April 2017

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in
this part.

Number & class of securities

Nil

+ See chapter 19 for defined terms.

11/3/2002

Appendix 3X  Page 1

Appendix 3X
Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

==> picture [414 x 128] intentionally omitted <==

----- Start of picture text ----- Name of holder & nature of interest Number & class of SecuritiesNote: Provide details of the circumstances giving rise to the relevant interest.Nil Nil----- End of picture text -----

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in
this part.

Nil

+ See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002